Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue: +64.0%
EPS: +525.8%
Free cash flow: +161.0%

Quarter to September 2026, against a year earlier

72.63 1.00 +1.40%

Follow CORT

Alert me

Market cap: $7.8B
P/E: 47.8×
Fwd P/E: 39.8×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	37.02	89.58	167.21	75.86
P/S ratio Full definition →		4.75	5.47	11.03	12.75
P/FCF ratio Full definition →		25.49	35.04	85.69	63.13
P/Operating CF Full definition →		94.01	(251.00)	273.16	85.99
P/B ratio Full definition →		5.58	6.60	12.98	14.74
Price to Tangible BV Full definition →		5.58	6.60	12.98	14.74
EV/Sales Full definition →		4.28	5.05	10.68	12.38
EV/EBITDA Full definition →		78.33	0.00	2,382.98	109.69
EV/Operating CF Full definition →		22.94	32.27	80.85	60.23
EV/FCF Full definition →		22.97	32.35	82.95	61.30
Quick Ratio Full definition →		2.60	2.53	2.50	2.71
Current Ratio Full definition →		2.92	2.86	2.86	3.00
Net Debt/EBITDA Full definition →		2,739.77	6.90	(7.31)	(3.20)
Debt/Assets Full definition →		0.60%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.01	0.00	0.00	0.00
Asset Turnover Full definition →		0.91	0.93	0.98	1.04
Operating CF/Net income Full definition →		1.61	0.54	0.80	1.15
Capex/Depreciation Full definition →		0.01	(0.34)	(2.93)	(0.69)
Research and Development Expense of Revenue Full definition →		32.09%	40.18%	21.04%	16.66%
Selling, General and Administrative Expense of Revenue Full definition →		64.43%	88.15%	61.25%	48.30%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		10.27%	13.97%	11.48%	8.65%
Graham Net Nets Full definition →		0.08	0.06	0.03	0.03
Graham Number Full definition →		11.49	7.86	8.85	16.35
Earnings Yield Full definition →		2.70%	1.12%	0.60%	1.32%
Free Cash Flow Yield Full definition →		3.92%	2.85%	1.17%	1.58%
Revenue per Share Full definition →		1.95	1.58	2.43	3.19
Operating CF per Share Full definition →		0.37	(0.16)	0.32	1.34
Capex per Share Full definition →		0.00	0.00	(0.02)	(0.01)
Free Cash Flow per Share Full definition →		0.37	(0.16)	0.29	1.33
Cash per Share Full definition →		3.58	3.24	2.92	3.48
Shareholders Equity per Share Full definition →		6.24	6.11	6.70	7.82
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		6.24	6.11	6.70	7.82
Free Cash Flow Full definition →		38.40	(16.97)	31.02	142.18
Working Capital Full definition →		319.38	276.85	285.87	356.20
Capital Expenditures Full definition →		(0.05)	(0.20)	(2.53)	(0.71)
Net Current Asset Value Full definition →		296.62	249.14	256.75	333.59
EV/EBIT Full definition →		72.71	0.00	1,384.77	107.58
Capex to Sales Full definition →		0.00	0.00	0.01	0.00
Price to Operating Income Full definition →		80.68	0.00	1,430.53	110.78
Other line items
Average Receivables Full definition →		56.88	50.45	70.74	90.35
Average Payables Full definition →		27.91	30.63	19.22	28.19
Average Inventory Full definition →		12.64	13.63	12.73	12.13
Average Assets Full definition →		838.60	830.67	845.21	928.82
Average Common Equity Full definition →		663.70	660.64	670.78	732.82

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly